成人午夜又粗又硬又长_鲁一鲁AV2019在线_欧美深深色噜噜狠狠yyy_www.91色.com_色影音先锋av资源网_特级做A爰片久久毛片A片喷水_99精品无人区乱码1区2区3区_国产人妻久久精品一区_欧美午夜精品久久久久久浪潮_av免费无码天堂在线_蜜桃色欲AV久久无码精品软件_日美一级毛片_久久久久久久久性潮_国产乱对白精彩_日韩精品免费一区二区_亚洲欧美精品在线_无码国产69精品久久久久_开心五月综合激情综合五月_干一夜综合_亚洲中文有码字幕日本

當前位置: 首頁 > 新聞 > 技術裝備
技術裝備
驗證主計劃和驗證計劃之間的關聯性
發布時間: 2025-04-10     來源: 制藥質量、研發、注冊交流
 

驗證主計劃和驗證計劃之間的關聯性


 

In a news item from 19 March 2025, we described deficiencies in microbiological tests of non-sterile products. However, the warning letter in question provides further information: on process validation. What was criticized?

2025319日的一篇新聞中內容見文末,我們描述了非無菌產品的微生物檢測缺陷。然而,有問題的警告信提供了進一步的信息:關于工藝驗證批評了什么?

The FDA found that although there were requirements in the Validation Master Plan for process validation and hold times, no operating conditions such as bulk hold times, process limits or acceptance criteria for process parameters were specified in the validation protocol itself.

FDA發現,雖然在驗證主計劃中對工藝驗證和保持時間有要求,但在驗證方案本身中沒有規定操作條件,如批保持時間、工藝限值或工藝參數的接受標準。

In response, the inspected company submitted an updated validation protocol which, according to the FDA, still failed to address hold times and other details, such as information on sampling and the batch report that is used for the first validation batch. Subsequently, the FDA refers to its process validation guideline and describes the content of the guideline in a short section of the warning letter. 

作為回復,被檢查的公司提交了一份更新的驗證方案,根據FDA的說法,該方案仍然沒有說明保持時間和其他細節,例如取樣信息和用于第一個驗證批次的批次報告。隨后,FDA引用了其工藝驗證指南,并在警告信的一小部分中描述了指南的內容。

Another point of criticism was the equipment. Contrary to the intended use, the circulation of the (water) system was stopped when it was not in operation. There was also a lack of monitoring of both chemical and microbiological parameters in accordance with the US Pharmacopoeia (USP). The response of the inspected company to operate the system permanently in the future is not sufficient. The entire system design is still to be assessed and monitoring introduced. In addition, the FDA requires interim measures and an investigation into the impact of the incorrectly validated system on product quality.

另一個批評點是設備。與預期用途相反,(水)系統在不運行時停止循環。也缺乏根據美國藥典(USP)對化學和微生物參數的監測。被檢查的公司對未來永久運行該系統的回復是不夠的。整個系統的設計還有待評估和監測。此外,FDA要求采取臨時措施并調查錯誤驗證系統對產品質量的影響

代理服務
主站蜘蛛池模板: 金山区| 元朗区| 澎湖县| 两当县| 渭南市| 光山县| 青海省| 洛隆县| 建湖县| 仁化县| 喀什市| 姜堰市| 开江县| 灵武市| 晋城| 上饶市| 若羌县| 当涂县| 田林县| 龙里县| 基隆市| 隆林| 沙河市| 鄂托克旗| 商丘市| 廉江市| 平江县| 万源市| 隆安县| 南丹县| 洞口县| 钟山县| 蓝山县| 辰溪县| 青阳县| 象山县| 新巴尔虎左旗| 北流市| 章丘市| 浦江县| 新河县|